These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32385160)

  • 1. ZBED2 is an antagonist of interferon regulatory factor 1 and modifies cell identity in pancreatic cancer.
    Somerville TDD; Xu Y; Wu XS; Maia-Silva D; Hur SK; de Almeida LMN; Preall JB; Koo PK; Vakoc CR
    Proc Natl Acad Sci U S A; 2020 May; 117(21):11471-11482. PubMed ID: 32385160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay between interferon regulatory factor 1 and BRD4 in the regulation of PD-L1 in pancreatic stellate cells.
    Ebine K; Kumar K; Pham TN; Shields MA; Collier KA; Shang M; DeCant BT; Urrutia R; Hwang RF; Grimaldo S; Principe DR; Grippo PJ; Bentrem DJ; Munshi HG
    Sci Rep; 2018 Sep; 8(1):13225. PubMed ID: 30185888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism.
    Perera RM; Stoykova S; Nicolay BN; Ross KN; Fitamant J; Boukhali M; Lengrand J; Deshpande V; Selig MK; Ferrone CR; Settleman J; Stephanopoulos G; Dyson NJ; Zoncu R; Ramaswamy S; Haas W; Bardeesy N
    Nature; 2015 Aug; 524(7565):361-5. PubMed ID: 26168401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer.
    Marin-Muller C; Li D; Bharadwaj U; Li M; Chen C; Hodges SE; Fisher WE; Mo Q; Hung MC; Yao Q
    Clin Cancer Res; 2013 Nov; 19(21):5901-13. PubMed ID: 23989979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ID1 Mediates Escape from TGFβ Tumor Suppression in Pancreatic Cancer.
    Huang YH; Hu J; Chen F; Lecomte N; Basnet H; David CJ; Witkin MD; Allen PJ; Leach SD; Hollmann TJ; Iacobuzio-Donahue CA; Massagué J
    Cancer Discov; 2020 Jan; 10(1):142-157. PubMed ID: 31582374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic analyses identify molecular subtypes of pancreatic cancer.
    Bailey P; Chang DK; Nones K; Johns AL; Patch AM; Gingras MC; Miller DK; Christ AN; Bruxner TJ; Quinn MC; Nourse C; Murtaugh LC; Harliwong I; Idrisoglu S; Manning S; Nourbakhsh E; Wani S; Fink L; Holmes O; Chin V; Anderson MJ; Kazakoff S; Leonard C; Newell F; Waddell N; Wood S; Xu Q; Wilson PJ; Cloonan N; Kassahn KS; Taylor D; Quek K; Robertson A; Pantano L; Mincarelli L; Sanchez LN; Evers L; Wu J; Pinese M; Cowley MJ; Jones MD; Colvin EK; Nagrial AM; Humphrey ES; Chantrill LA; Mawson A; Humphris J; Chou A; Pajic M; Scarlett CJ; Pinho AV; Giry-Laterriere M; Rooman I; Samra JS; Kench JG; Lovell JA; Merrett ND; Toon CW; Epari K; Nguyen NQ; Barbour A; Zeps N; Moran-Jones K; Jamieson NB; Graham JS; Duthie F; Oien K; Hair J; Grützmann R; Maitra A; Iacobuzio-Donahue CA; Wolfgang CL; Morgan RA; Lawlor RT; Corbo V; Bassi C; Rusev B; Capelli P; Salvia R; Tortora G; Mukhopadhyay D; Petersen GM; ; Munzy DM; Fisher WE; Karim SA; Eshleman JR; Hruban RH; Pilarsky C; Morton JP; Sansom OJ; Scarpa A; Musgrove EA; Bailey UM; Hofmann O; Sutherland RL; Wheeler DA; Gill AJ; Gibbs RA; Pearson JV; Waddell N; Biankin AV; Grimmond SM
    Nature; 2016 Mar; 531(7592):47-52. PubMed ID: 26909576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GLI1 facilitates the migration and invasion of pancreatic cancer cells through MUC5AC-mediated attenuation of E-cadherin.
    Inaguma S; Kasai K; Ikeda H
    Oncogene; 2011 Feb; 30(6):714-23. PubMed ID: 20972463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The basic helix-loop-helix transcription factor E47 reprograms human pancreatic cancer cells to a quiescent acinar state with reduced tumorigenic potential.
    Kim S; Lahmy R; Riha C; Yang C; Jakubison BL; van Niekerk J; Staub C; Wu Y; Gates K; Dong DS; Konieczny SF; Itkin-Ansari P
    Pancreas; 2015 Jul; 44(5):718-27. PubMed ID: 25894862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia but not normoxia promotes Smoothened transcription through upregulation of RBPJ and Mastermind-like 3 in pancreatic cancer.
    Onishi H; Yamasaki A; Kawamoto M; Imaizumi A; Katano M
    Cancer Lett; 2016 Feb; 371(2):143-50. PubMed ID: 26655998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro.
    Huang FT; Peng JF; Cheng WJ; Zhuang YY; Wang LY; Li CQ; Tang J; Chen WY; Li YH; Zhang SN
    Dig Dis Sci; 2017 Apr; 62(4):944-957. PubMed ID: 28194669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma.
    Somerville TDD; Xu Y; Miyabayashi K; Tiriac H; Cleary CR; Maia-Silva D; Milazzo JP; Tuveson DA; Vakoc CR
    Cell Rep; 2018 Nov; 25(7):1741-1755.e7. PubMed ID: 30428345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MUC1 regulates PDGFA expression during pancreatic cancer progression.
    Sahraei M; Roy LD; Curry JM; Teresa TL; Nath S; Besmer D; Kidiyoor A; Dalia R; Gendler SJ; Mukherjee P
    Oncogene; 2012 Nov; 31(47):4935-45. PubMed ID: 22266848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circ-ASH2L promotes tumor progression by sponging miR-34a to regulate Notch1 in pancreatic ductal adenocarcinoma.
    Chen Y; Li Z; Zhang M; Wang B; Ye J; Zhang Y; Tang D; Ma D; Jin W; Li X; Wang S
    J Exp Clin Cancer Res; 2019 Nov; 38(1):466. PubMed ID: 31718694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased zinc and downregulation of ZIP3 zinc uptake transporter in the development of pancreatic adenocarcinoma.
    Costello LC; Levy BA; Desouki MM; Zou J; Bagasra O; Johnson LA; Hanna N; Franklin RB
    Cancer Biol Ther; 2011 Aug; 12(4):297-303. PubMed ID: 21613827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HNF-1a promotes pancreatic cancer growth and apoptosis resistance via its target gene PKLR.
    Fan Z; Fan K; Deng S; Gong Y; Qian Y; Huang Q; Yang C; Cheng H; Jin K; Luo G; Liu C; Yu X
    Acta Biochim Biophys Sin (Shanghai); 2020 Mar; 52(3):241-250. PubMed ID: 32072180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mucus production programme promotes classical pancreatic ductal adenocarcinoma.
    Tonelli C; Yordanov GN; Hao Y; Deschênes A; Hinds J; Belleau P; Klingbeil O; Brosnan E; Doshi A; Park Y; Hruban RH; Vakoc CR; Dobin A; Preall J; Tuveson DA
    Gut; 2024 May; 73(6):941-954. PubMed ID: 38262672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles of interferon regulatory factors 1 and 2 in the progression of human pancreatic cancer.
    Sakai T; Mashima H; Yamada Y; Goto T; Sato W; Dohmen T; Kamada K; Yoshioka M; Uchinami H; Yamamoto Y; Ohnishi H
    Pancreas; 2014 Aug; 43(6):909-16. PubMed ID: 24632547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFN-γ-mediated IRF1/miR-29b feedback loop suppresses colorectal cancer cell growth and metastasis by repressing IGF1.
    Yuan L; Zhou C; Lu Y; Hong M; Zhang Z; Zhang Z; Chang Y; Zhang C; Li X
    Cancer Lett; 2015 Apr; 359(1):136-47. PubMed ID: 25592039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-371-5p facilitates pancreatic cancer cell proliferation and decreases patient survival.
    He D; Miao H; Xu Y; Xiong L; Wang Y; Xiang H; Zhang H; Zhang Z
    PLoS One; 2014; 9(11):e112930. PubMed ID: 25411783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis.
    Zhou R; Curry JM; Roy LD; Grover P; Haider J; Moore LJ; Wu ST; Kamesh A; Yazdanifar M; Ahrens WA; Leung T; Mukherjee P
    Oncogene; 2016 Oct; 35(43):5608-5618. PubMed ID: 26804176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.